Alteration of Telomerase Activity in Ovarian Cancer after Chemotherapy

Publisher： Karger

E-ISSN： 1423-002x|49|3|204-208

ISSN： 0378-7346

Source： Gynecologic and Obstetric Investigation, Vol.49, Iss.3, 2000-04, pp. : 204-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pilot Phase 2 Trial of 4 Months of Maintenance Pegylated Liposomal Doxorubicin in Patients with Advanced Ovarian Cancer after Complete Response to Platinum and Paclitaxel-Based Chemotherapy

By  

Gynecologic and Obstetric Investigation, Vol. 63, Iss. 1, 2006-06 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Blood Flow after Intraarterial Infusion Chemotherapy in a Patient with Advanced Cervical Cancer

By  

Gynecologic and Obstetric Investigation, Vol. 52, Iss. 4, 2001-11 ,pp. : 278-280

Karger

Access to resources Recommend Favorite

Role of Extended Chemotherapy in Advanced Ovarian Cancer Patients with High Posttreatment Serum CA-125 Levels

By  

Gynecologic and Obstetric Investigation, Vol. 72, Iss. 1, 2011-03 ,pp. : 50-54

Karger

Access to resources Recommend Favorite

Assessment of Apoptotic Activity Dysregulation and Oxidative Stress in the Development of Epithelial Ovarian Cancer: A Case-Controlled Descriptive Analysis

By  

Gynecologic and Obstetric Investigation, Vol. 81, Iss. 1, 2016-0 ,pp. : 71-77

Karger

Access to resources Recommend Favorite

A Rare Case of Peritoneal Disseminated Angiosarcoma 20 Years after Ovarian Cancer Diagnosis

By  

Gynecologic and Obstetric Investigation, Vol. 77, Iss. 1, 2013-12 ,pp. : 68-72

Karger

Access to resources Recommend Favorite